HomePANG • BME
add
Pangaea Oncology SA
Previous close
€1.75
Year range
€1.68 - €2.42
Market cap
53.36M EUR
Avg Volume
56.08K
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 1.74M | 3.31% |
Operating expense | 1.85M | 18.99% |
Net income | -459.78K | 0.84% |
Net profit margin | -26.44 | 3.99% |
Earnings per share | — | — |
EBITDA | -497.30K | -1,140.05% |
Effective tax rate | 3.65% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.07M | -61.82% |
Total assets | 25.46M | -22.36% |
Total liabilities | 5.61M | -22.59% |
Total equity | 19.85M | — |
Shares outstanding | 29.45M | — |
Price to book | 2.61 | — |
Return on assets | -5.91% | — |
Return on capital | -6.78% | — |
Cash Flow
Net change in cash
(EUR) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -459.78K | 0.84% |
Cash from operations | -460.08K | 21.29% |
Cash from investing | -76.75K | -620.54% |
Cash from financing | -1.25M | -121.70% |
Net change in cash | -1.79M | -134.57% |
Free cash flow | -119.79K | -384.87% |
About
Founded
2006
Website
Employees
58